Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Smooth | 3 | 2022 | 931 | 0.840 |
Why?
|
Muscle Contraction | 3 | 2022 | 1207 | 0.720 |
Why?
|
Respiratory Hypersensitivity | 1 | 2021 | 271 | 0.670 |
Why?
|
STAT1 Transcription Factor | 1 | 2021 | 340 | 0.670 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 433 | 0.630 |
Why?
|
Pulmonary Artery | 4 | 2024 | 1937 | 0.570 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2022 | 701 | 0.420 |
Why?
|
Myocytes, Cardiac | 1 | 2018 | 1672 | 0.330 |
Why?
|
Tissue Engineering | 1 | 2018 | 1857 | 0.300 |
Why?
|
Sirtuin 3 | 2 | 2024 | 66 | 0.280 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2022 | 1494 | 0.240 |
Why?
|
Asthma | 2 | 2021 | 6268 | 0.240 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 330 | 0.210 |
Why?
|
Hypertension, Pulmonary | 2 | 2024 | 1604 | 0.210 |
Why?
|
Cholinergic Agents | 1 | 2021 | 97 | 0.190 |
Why?
|
Theta Rhythm | 1 | 2023 | 220 | 0.190 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2017 | 4627 | 0.180 |
Why?
|
Taiwan | 3 | 2017 | 521 | 0.170 |
Why?
|
Stroke Volume | 2 | 2024 | 5595 | 0.170 |
Why?
|
Sphingosine | 1 | 2021 | 306 | 0.160 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2017 | 37 | 0.140 |
Why?
|
Arteries | 1 | 2022 | 1120 | 0.140 |
Why?
|
Cells, Cultured | 3 | 2024 | 18962 | 0.130 |
Why?
|
Bronchial Hyperreactivity | 1 | 2017 | 300 | 0.130 |
Why?
|
Mice, Knockout | 4 | 2024 | 14450 | 0.120 |
Why?
|
Depressive Disorder, Major | 2 | 2023 | 4805 | 0.110 |
Why?
|
Lung | 2 | 2022 | 10046 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2455 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2021 | 3158 | 0.100 |
Why?
|
Stroke | 1 | 2015 | 9739 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2024 | 4959 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2877 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2021 | 3225 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18292 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3690 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3906 | 0.090 |
Why?
|
Heart Failure | 2 | 2024 | 11837 | 0.080 |
Why?
|
Sex Distribution | 1 | 2015 | 2269 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1804 | 0.080 |
Why?
|
Age Distribution | 1 | 2015 | 2864 | 0.080 |
Why?
|
Dermatitis, Atopic | 1 | 2016 | 724 | 0.080 |
Why?
|
Mice | 4 | 2024 | 81782 | 0.080 |
Why?
|
Animals | 8 | 2024 | 168735 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2016 | 1238 | 0.070 |
Why?
|
Comorbidity | 3 | 2017 | 10575 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2963 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2596 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6321 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3247 | 0.050 |
Why?
|
Epilepsy | 1 | 2017 | 3317 | 0.050 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2023 | 1496 | 0.050 |
Why?
|
Signal Transduction | 2 | 2022 | 23597 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 3719 | 0.050 |
Why?
|
Humans | 12 | 2024 | 765926 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2023 | 2223 | 0.050 |
Why?
|
Incidence | 2 | 2016 | 21513 | 0.040 |
Why?
|
Antidepressive Agents | 2 | 2023 | 2901 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14745 | 0.040 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2017 | 81 | 0.030 |
Why?
|
Cell Respiration | 1 | 2017 | 197 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2017 | 247 | 0.030 |
Why?
|
Acetylcholine | 1 | 2017 | 628 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1054 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 465 | 0.030 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 393 | 0.030 |
Why?
|
Respiratory System | 1 | 2017 | 562 | 0.030 |
Why?
|
Bronchi | 1 | 2017 | 843 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22327 | 0.030 |
Why?
|
Cell Movement | 1 | 2024 | 5190 | 0.020 |
Why?
|
Cell Death | 1 | 2017 | 1676 | 0.020 |
Why?
|
Male | 6 | 2024 | 363815 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3586 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3930 | 0.020 |
Why?
|
Risk Factors | 2 | 2016 | 74850 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2219 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2022 | 2894 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1504 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2141 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 223016 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223088 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10426 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23708 | 0.020 |
Why?
|
Electroencephalography | 1 | 2023 | 6274 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22228 | 0.020 |
Why?
|
Female | 4 | 2024 | 396141 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39228 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12417 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3684 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9296 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3669 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8060 | 0.010 |
Why?
|
Smoking | 1 | 2017 | 9082 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13614 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8223 | 0.010 |
Why?
|
Aged | 2 | 2024 | 171163 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 26380 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36426 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42510 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65194 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59496 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 59857 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2016 | 81537 | 0.000 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore